Rapport Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023
Market Capitalization	883	-
Enterprise Value	709	-145
EV/EBITDA Ratio	-	4.22
EV/EBIT Ratio	-	4.18
EV/FCF Ratio	-	5.05
Debt / Equity Ratio	-0.05	-0.08
Debt / EBITDA Ratio	-	-0.06
Debt / FCF Ratio	-	-0.07
Quick Ratio	19.56	16.76
Current Ratio	20.10	17.14
Return on Equity (ROE)	-	194.90%
Return on Assets (ROA)	-	-37.20%
Return on Capital (ROIC)	-	154.03%
Earnings Yield	-5.70%	-
Buyback Yield / Dilution	-93.74%
Total Shareholder Return	-93.74%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).